Whalegun
Home

Justin B. Klee, Co-CEO: Amylyx Pharmaceuticals AMLX Sell · Filed 25/10/02

Trade details

Type
Insider sale
Amount
$427,866.75
Shares · price
29,775 sh · $14.37 a share
Held after
3,325,501 sh
Stock
Amylyx Pharmaceuticals AMLX
Person
Justin B. KleeCo-CEO
Trade date
25/09/30
Filed
25/10/02
Days to filing
2 days

Sold 0.9% of holdings

Share of holding sold
0.9%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Justin B. Klee's recent trades

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $980.3K

    Filed 09/11

  • Justin B. Klee

    SellAmylyx Pharmaceuticals

    $423.7K

    Filed 03/04

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $423.8K

    Filed 03/02

  • Justin B. Klee

    SellAmylyx Pharmaceuticals

    $227.7K

    Filed 02/04

  • Justin B. Klee

    Planned saleAmylyx Pharmaceuticals

    $227.6K

    Filed 02/02

Justin B. Klee, CEO — sold $427.9K of Amylyx Pharmaceuticals AMLX · 0.9% of holdings | Whalegun